ACVBP Followed by ASCT in Patients With BCL-2 Positive Diffuse Large B-Cell Lymphoma

NCT00169130 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma, Large-Cell, Diffuse

Interventions

DRUG: doxorubicin
DRUG: cyclophosphamide
PROCEDURE: Autologous stem cell transplantation

Sponsor

Lymphoma Study Association

Collaborators

[object Object]